These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2149985)

  • 1. [Possible role of altered levels of plasma docosahexaenoic acid in the pathogenesis of retinitis pigmentosa. Preliminary results].
    Simonelli F; Milone A; Iura A; Picardi C; La Banca AM; Cotticelli L; Rinaldi E
    Boll Soc Ital Biol Sper; 1990 Sep; 66(9):893-8. PubMed ID: 2149985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa.
    Gong J; Rosner B; Rees DG; Berson EL; Weigel-DiFranco CA; Schaefer EJ
    Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2596-602. PubMed ID: 1386350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipid abnormalities in retinitis pigmentosa and related conditions.
    Converse CA; Hammer HM; Packard CJ; Shepherd J
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 5)():508-12. PubMed ID: 6591588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of fatty acids in membrane phospholipids of erythrocytes in retinitis pigmentosa patients.
    Simonelli F; Manna C; Romano N; Nunziata G; Voto O; Rinaldi E
    Ophthalmic Res; 1996; 28(2):93-8. PubMed ID: 8792359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell fatty acid levels in patients with autosomal dominant retinitis pigmentosa.
    Hoffman DR; Uauy R; Birch DG
    Exp Eye Res; 1993 Sep; 57(3):359-68. PubMed ID: 8224023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of omega-3 fatty acids in patients with autosomal dominant retinitis pigmentosa.
    Hoffman DR; Uauy R; Birch DG
    Exp Eye Res; 1995 Mar; 60(3):279-89. PubMed ID: 7789408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on blood from patients with dominantly-inherited retinitis pigmentosa.
    Voaden MJ; Polkinghorne PJ; Belin J; Smith AD
    Prog Clin Biol Res; 1989; 314():57-68. PubMed ID: 2608680
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenomedullin plasma concentrations in patients with retinitis pigmentosa.
    Vingolo EM; Lupo S; Domanico D; Cotesta D; Petramala L; Grenga R; Letizia C
    Clin Biochem; 2005 Aug; 38(8):735-8. PubMed ID: 15936747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic acid metabolism and inherited retinal degenerations.
    Bazan NG; Scott BL
    Prog Clin Biol Res; 1987; 247():103-18. PubMed ID: 2891142
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyunsaturated fatty acids are lower in blood lipids of Usher's type I but not Usher's type II.
    Maude MB; Anderson EO; Anderson RE
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2164-6. PubMed ID: 9761296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in Usher's syndrome.
    Bazan NG; Scott BL; Reddy TS; Pelias MZ
    Biochem Biophys Res Commun; 1986 Dec; 141(2):600-4. PubMed ID: 2948509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of plasma n-3 fatty acid levels in a family with X-linked retinitis pigmentosa.
    McLachlan T; McColl AJ; Collins MF; Converse CA; Packard CJ; Shepherd J
    Biochem Soc Trans; 1990 Oct; 18(5):905-6. PubMed ID: 2150655
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and serum lipid findings in a large family with autosomal dominant retinitis pigmentosa.
    Newsome DA; Anderson RE; May JG; McKay TA; Maude M
    Ophthalmology; 1988 Dec; 95(12):1691-5. PubMed ID: 3266001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal plasma levels of polyunsaturated fatty acid in autosomal dominant retinitis pigmentosa.
    Anderson RE; Maude MB; Lewis RA; Newsome DA; Fishman GA
    Exp Eye Res; 1987 Jan; 44(1):155-9. PubMed ID: 2951269
    [No Abstract]   [Full Text] [Related]  

  • 15. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa.
    Schaefer EJ; Robins SJ; Patton GM; Sandberg MA; Weigel-DiFranco CA; Rosner B; Berson EL
    J Lipid Res; 1995 Jul; 36(7):1427-33. PubMed ID: 7595066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sperm abnormalities in retinitis pigmentosa.
    Connor WE; Weleber RG; DeFrancesco C; Lin DS; Wolf DP
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2619-28. PubMed ID: 9375581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroretinographic findings in retinitis pigmentosa.
    Berson EL
    Jpn J Ophthalmol; 1987; 31(3):327-48. PubMed ID: 2448510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinitis pigmentosa in Spain. The Spanish Multicentric and Multidisciplinary Group for Research into Retinitis Pigmentosa.
    Ayuso C; Garcia-Sandoval B; Najera C; Valverde D; Carballo M; Antiñolo G
    Clin Genet; 1995 Sep; 48(3):120-2. PubMed ID: 8556816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinopathy mutations in the bZIP protein NRL alter phosphorylation and transcriptional activity.
    Kanda A; Friedman JS; Nishiguchi KM; Swaroop A
    Hum Mutat; 2007 Jun; 28(6):589-98. PubMed ID: 17335001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.